Zachary C Hartman

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Duke University. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zachary C Hartman. Retrieved from https://idiyas.com/inventor/zachary-c-hartman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

8 out of 2,084

Duke University

patents

Years Active: 2018-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12083172 - Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same (2024-09-10),

2. 11253580 - Cancer vaccines and methods of delivery (2022-02-22),

3. 11235043 - Vaccines against antigens involved in therapy resistance and methods of using same (2022-02-01),

4. 11224665 - Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same (2022-01-18),

5. 10842857 - Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same (2020-11-24),

6. 10842855 - Vaccines against an oncogenic isoform of ESR1 and methods of using the same (2020-11-24),

7. 10487143 - Vaccines against HER3 antigens and methods of using the same (2019-11-26),

8. 9956276 - Vaccines against antigens involved in therapy resistance and methods of using same (2018-05-01),

Title: Innovations in Cancer Treatment by Zachary C Hartman

Introduction

Zachary C Hartman is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of cancer therapeutics. With a total of 8 patents, Hartman has focused on developing innovative vaccines aimed at combating cancer and precancerous conditions.

Latest Patents

Hartman's latest patents include groundbreaking work on vaccines against an oncogenic isoform of HER2 (ErbB2). These methods aim to reduce the likelihood of cancer or precancer developing resistance to therapeutic agents. The vaccines utilize a polynucleotide encoding a polypeptide correlated with resistance development, which can be administered alongside cancer therapeutics or immunomodulatory agents. Additionally, he has developed compositions and methods for delivering cancer vaccines, emphasizing combination treatments that enhance the efficacy of immunomodulatory agents.

Career Highlights

Zachary C Hartman is affiliated with Duke University, where he continues to advance research in cancer treatment. His work has garnered attention for its potential to improve patient outcomes through innovative vaccine strategies.

Collaborations

Hartman collaborates with esteemed colleagues, including Herbert K Lyerly and Takuya Osada, to further enhance the impact of his research in the field of oncology.

Conclusion

Zachary C Hartman's contributions to cancer treatment through innovative vaccine development highlight his role as a leading inventor in the medical field. His work promises to pave the way for more effective cancer therapies in the future.

Profile summary based on public USPTO records.